Related Experiment Video
Updated: May 16, 2025

Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid
Published on: January 19, 2024
The potential role of tranexamic acid and botulinum toxin in treating patients with acne vulgaris: a split face
Mohamed Metwalli1, Amina Ali Mohamed1, Reham Essam2
1Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
Background:
Many causes can lead to acne, such as increased sebum production, altered sebum lipid quality from increased androgen activity, abnormal keratinization of the infundibular epithelium, and Propionibacterium acnes (P. acnes) colonizing the follicles.
Aim:
The present study aimed to evaluate and compare the clinical efficacy of botulinum toxin-A vs. tranexamic acid intradermal injection in the treatment of acne vulgaris.
Methods:
This split face study includes forty patients with varying grades of acne vulgaris. They were injected intradermally with tranexamic acid (20 mg/ml) on the left side for three sessions two weeks apart and once with botulinum toxin-A on the right side.
Results:
After treatment, the Total Lesion Count, Comprehensive Acne severity Scale, and Clinical Erythema Assessment Scale significantly reduced, with a greater reduction in erythema on the tranexamic acid side and a greater reduction of comedones on the botulinum toxin side.
Conclusion:
Tranexamic acid and botulinum toxin-A can be promising adjuvants in treating acne vulgaris by their specific mechanisms in the dermatological domain.
Related Concept Videos
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Skeletal Muscle Relaxants: Therapeutic Uses
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Prevention of Further Absorption of Poison
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...
Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...

